Pretreatment quality of life and survival in patients with lung cancer: a systematic review and meta-analysis

Abstract Background Although many studies have explored the correlation between quality of life and survival, none have reported this relationship for specific cancers assessed at distinct time points. This meta-analysis aimed to investigate the impact of pretreatment Global Quality of Life (QOL) an...

Full description

Bibliographic Details
Main Authors: Taro Okayama, Katsuyoshi Suzuki, Shinichiro Morishita, Junichiro Inoue, Takashi Tanaka, Jiro Nakano, Takuya Fukushima
Format: Article
Language:English
Published: BMC 2024-04-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-024-12267-w
_version_ 1797199411623755776
author Taro Okayama
Katsuyoshi Suzuki
Shinichiro Morishita
Junichiro Inoue
Takashi Tanaka
Jiro Nakano
Takuya Fukushima
author_facet Taro Okayama
Katsuyoshi Suzuki
Shinichiro Morishita
Junichiro Inoue
Takashi Tanaka
Jiro Nakano
Takuya Fukushima
author_sort Taro Okayama
collection DOAJ
description Abstract Background Although many studies have explored the correlation between quality of life and survival, none have reported this relationship for specific cancers assessed at distinct time points. This meta-analysis aimed to investigate the impact of pretreatment Global Quality of Life (QOL) and functioning QOL, including physical, social, role, emotional, and cognitive QOLs, on mortality risk in patients with lung cancer. Methods A literature search was conducted across the Cumulative Index to Nursing and Allied Health Literature (CINAHL), Scopus, and PubMed databases for articles published between their inception and December 2022. Subsequently, 11 studies were selected based on predefined eligibility criteria to investigate the relationship between pretreatment QOLs and mortality risk in patients with lung cancer. Results Pretreatment global, physical, social, role, and emotional QOLs were significantly associated with mortality risk as follows: Global QOL (hazard ratio [HR] = 1.08 95% confidence interval [CI] = 1.03–1.13); Physical QOL (HR = 1.04 95% CI = 1.02–1.05); Social QOL (HR = 1.02 95% CI = 1.01–1.03; Role QOL (HR = 1.01 95% CI = 1.01–1.02); Emotional QOL (HR = 1.01 95% CI = 1.00–1.03). Conclusions These findings underscore the importance of early QOL assessment after diagnosis as well as early provision of physical, social, and psychological support accommodating each patient’s demands. Trial registration The International Prospective Register of Systematic Reviews registration number CRD42023398206, Registered on February 20, 2023.
first_indexed 2024-04-24T07:15:20Z
format Article
id doaj.art-9c581b0a76d84c47a0b4c32a25306350
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-04-24T07:15:20Z
publishDate 2024-04-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-9c581b0a76d84c47a0b4c32a253063502024-04-21T11:21:42ZengBMCBMC Cancer1471-24072024-04-0124111110.1186/s12885-024-12267-wPretreatment quality of life and survival in patients with lung cancer: a systematic review and meta-analysisTaro Okayama0Katsuyoshi Suzuki1Shinichiro Morishita2Junichiro Inoue3Takashi Tanaka4Jiro Nakano5Takuya Fukushima6Division of Rehabilitation Medicine, Shizuoka Cancer CenterDivision of Rehabilitation Medicine, Shizuoka Cancer CenterDepartment of Physical Therapy, School of Health Science, Fukushima Medical UniversityDivision of Rehabilitation Medicine, Kobe University Hospital International Clinical Cancer Research CenterDepartment of Rehabilitation, Hyogo Medical University HospitalFaculty of Rehabilitation, Kansai Medical UniversityFaculty of Rehabilitation, Kansai Medical UniversityAbstract Background Although many studies have explored the correlation between quality of life and survival, none have reported this relationship for specific cancers assessed at distinct time points. This meta-analysis aimed to investigate the impact of pretreatment Global Quality of Life (QOL) and functioning QOL, including physical, social, role, emotional, and cognitive QOLs, on mortality risk in patients with lung cancer. Methods A literature search was conducted across the Cumulative Index to Nursing and Allied Health Literature (CINAHL), Scopus, and PubMed databases for articles published between their inception and December 2022. Subsequently, 11 studies were selected based on predefined eligibility criteria to investigate the relationship between pretreatment QOLs and mortality risk in patients with lung cancer. Results Pretreatment global, physical, social, role, and emotional QOLs were significantly associated with mortality risk as follows: Global QOL (hazard ratio [HR] = 1.08 95% confidence interval [CI] = 1.03–1.13); Physical QOL (HR = 1.04 95% CI = 1.02–1.05); Social QOL (HR = 1.02 95% CI = 1.01–1.03; Role QOL (HR = 1.01 95% CI = 1.01–1.02); Emotional QOL (HR = 1.01 95% CI = 1.00–1.03). Conclusions These findings underscore the importance of early QOL assessment after diagnosis as well as early provision of physical, social, and psychological support accommodating each patient’s demands. Trial registration The International Prospective Register of Systematic Reviews registration number CRD42023398206, Registered on February 20, 2023.https://doi.org/10.1186/s12885-024-12267-wQuality of lifeLung cancerMortality riskSystematic reviewMeta-analysis
spellingShingle Taro Okayama
Katsuyoshi Suzuki
Shinichiro Morishita
Junichiro Inoue
Takashi Tanaka
Jiro Nakano
Takuya Fukushima
Pretreatment quality of life and survival in patients with lung cancer: a systematic review and meta-analysis
BMC Cancer
Quality of life
Lung cancer
Mortality risk
Systematic review
Meta-analysis
title Pretreatment quality of life and survival in patients with lung cancer: a systematic review and meta-analysis
title_full Pretreatment quality of life and survival in patients with lung cancer: a systematic review and meta-analysis
title_fullStr Pretreatment quality of life and survival in patients with lung cancer: a systematic review and meta-analysis
title_full_unstemmed Pretreatment quality of life and survival in patients with lung cancer: a systematic review and meta-analysis
title_short Pretreatment quality of life and survival in patients with lung cancer: a systematic review and meta-analysis
title_sort pretreatment quality of life and survival in patients with lung cancer a systematic review and meta analysis
topic Quality of life
Lung cancer
Mortality risk
Systematic review
Meta-analysis
url https://doi.org/10.1186/s12885-024-12267-w
work_keys_str_mv AT tarookayama pretreatmentqualityoflifeandsurvivalinpatientswithlungcancerasystematicreviewandmetaanalysis
AT katsuyoshisuzuki pretreatmentqualityoflifeandsurvivalinpatientswithlungcancerasystematicreviewandmetaanalysis
AT shinichiromorishita pretreatmentqualityoflifeandsurvivalinpatientswithlungcancerasystematicreviewandmetaanalysis
AT junichiroinoue pretreatmentqualityoflifeandsurvivalinpatientswithlungcancerasystematicreviewandmetaanalysis
AT takashitanaka pretreatmentqualityoflifeandsurvivalinpatientswithlungcancerasystematicreviewandmetaanalysis
AT jironakano pretreatmentqualityoflifeandsurvivalinpatientswithlungcancerasystematicreviewandmetaanalysis
AT takuyafukushima pretreatmentqualityoflifeandsurvivalinpatientswithlungcancerasystematicreviewandmetaanalysis